Jeff Yass’s enGene Therapeutics Warrants ENGNW Stock Holding History
Bought
Maintained
Sold
Other funds holding ENGNW
CL
Jeff Yass's ENGNW Position: Q3 2026 in Review
Jeff Yass opened a new position in enGene Therapeutics Warrants (ENGNW) in Q3 2026: 16,801 shares worth $3.36K. The stake represents ﹤0.01% of the portfolio and ranks #13309 among its holdings.
12 funds tracked by Wall St. Rank hold ENGNW as of Q3 2026.
- Jeff Yass held 16,801 shares of enGene Therapeutics Warrants worth $3.36K as of Q3 2026.
- enGene Therapeutics Warrants was a new Jeff Yass position in Q3 2026.
- enGene Therapeutics Warrants made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #13309 holding.
- 12 funds tracked by Wall St. Rank held enGene Therapeutics Warrants as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.